Canada

PegLyte Powder recalled over possible contamination

Updated: 

Published: 

Health Canada has issued a recall for four lots of Pendopharm's PegLyte Powder over possible contamination. (Health Canada)

Canadians who use a commonly available medication for bowel preparation are being urged to check their supplies after a recall was announced over possible contamination.

The federal health agency posted a recall notice on Tuesday for four lots of Pendopharm’s PegLyte Powder after the products were found to potentially contain foreign matter.

The recall applies to products with the following lot numbers: 260303, 260304, 260305 and 260306.

What consumers should do

Health Canada is advising consumers to verify whether their product belongs to one of the affected lots.

Anyone with an affected product should consult their health-care provider before discontinuing its use. Consumers with health concerns are also encouraged to seek medical advice.

Reporting side effects and complaints

Health Canada is also reminding consumers that they can report any health product-related side effects through its online reporting system⁠.

Other health product safety concerns can be submitted through the agency’s health product complaint process⁠.